INS and diabetes mellitus: In yet another study, patients without diabetes with IBD were treated with anti-tumor necrosis factor alfa to examine insulin resistance with regards to insulin concentrations and HOMA-IR, showing a significantly improved insulin sensitivity compared with controls treated with aminosalicylates (21).